foxo4-dri peptide senolytic animal model 2023 FOXO4-DRI: The Senolytic Peptide That

The invention also relates to novel uses and methods of treatments using the aforementioned salts and/or compositions, in particular, with respect to the treatment of disturbances connected with either nitric oxide (NO) formation or impaired NO-system functions, in particular, hypertension, angina, impotence, circulatory and septic shock, stroke, inflammation, respiratory distress syndrome, adhesion and aggregation of platelets and leukocytes, endothelial dysfunction, gastrointestinal lesions, peristalsis disturbances, diabetes, pancreatitis, hypotension and Parkinson's disease

Legal Status and Dosing BPC-157 is not approved for human use

I use a smart watch

BPC-157 is a synthetic peptide commonly studied in laboratory environments as part of peptide chemistry and molecular research